))
Beyond the Trip: Psychedelics and Their Impact on Healthcare
Manage episode 430665141 series 3046075
Content provided by Vynamic. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Vynamic or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
The re-emergence of clinical research into psychedelics as mental health treatment has become a promising development – particularly in light of the current global mental health crisis. However, persistent stigma around psychedelics, regulatory hurdles, and research challenges are a few factors to overcome before psychedelics could be more widely available. In today’s episode, Jen is joined by Vynamic’s Nick Fletcher and Grace Burtonwood to shine light on the opportunities and challenges psychedelics present to the mental health market.
Podcast Tags: healthcare, life sciences, healthcare news, mental health, psychedelics
Source Links:
- WHO Topics: Mental Health
- WHO Fact Sheets: Mental Disorders
- WHO: Global Health Estimates
- Multidisciplinary Association for Psychedelic Studies (MAPS)
- National Institute on Drug Abuse (NIDA)
- Compass Pathways
- BBC – FDA Advisory Committee Vote on MDMA
- FDA Guidance on Clinical Trials with Psychedelic Drugs
- How To Change Your Mind (Michael Pollen)
- European Medicines Agency (EMA)
Panel – Grace Burtonwood, Jen Burke, Nick Fletcher
Research & Production – Everly Petruzzelli, Nick Fletcher
Recording & Editing – Mike Liberto, Rachel Skonecki
For additional discussion, please contact us at TrendingHealth.com or share a voicemail at 1-888-VYNAMIC.
187 episodes
Share
